8-K: AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2024 Results, Provides 2025 Outlook

AdaptHealth Corp. reports its financial results for Q4 and the full year 2024, showing increased full-year revenue and provides its financial outlook for 2025.

Summary

• AdaptHealth Corp. announced its financial results for the fourth quarter and fiscal year ended December 31, 2024.
• Full year 2024 net revenue increased by 1.9% to $3,261.0 million compared to $3,200.2 million in 2023.
• Net income attributable to AdaptHealth Corp. was $90.4 million, a significant improvement from the $678.9 million net loss in the previous year.
• Adjusted EBITDA for the full year rose by 2.7% to $688.7 million from $670.8 million.
• Cash flow from operations increased to $541.8 million from $480.7 million, and free cash flow increased to $235.8 million from $143.2 million.
• Fourth quarter net revenue decreased slightly by 0.2% to $856.6 million compared to $858.2 million in the same period last year.
• Net income attributable to AdaptHealth Corp. for the fourth quarter was $50.3 million, compared to a net loss of $254.5 million in Q4 2023.
• Adjusted EBITDA for the fourth quarter decreased by 2.0% to $200.6 million from $204.6 million.
• Cash flow from operations for the fourth quarter decreased to $150.4 million from $155.3 million, while free cash flow increased to $73.1 million from $66.6 million.
• The company is providing its financial guidance for fiscal year 2025, including net revenue of $3.22 billion to $3.36 billion, adjusted EBITDA of $670 million to $710 million, and free cash flow of $180 million to $220 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the improved full-year results, particularly the turnaround to net income and increased free cash flow. However, the slight decrease in Q4 revenue and adjusted EBITDA tempers the overall positive outlook.

Positives

• Full-year net revenue increased by 1.9% to $3,261.0 million.
• The company achieved a net income of $90.4 million for the full year, a significant improvement from the previous year's net loss of $678.9 million.
• Adjusted EBITDA for the full year increased by 2.7% to $688.7 million.
• Cash flow from operations increased to $541.8 million from $480.7 million.
• Free cash flow increased to $235.8 million from $143.2 million.
• Net income attributable to AdaptHealth Corp. for the fourth quarter was $50.3 million, compared to a net loss of $254.5 million in Q4 2023.

Negatives

• Fourth quarter net revenue decreased slightly by 0.2% to $856.6 million.
• Adjusted EBITDA for the fourth quarter decreased by 2.0% to $200.6 million.
• Cash flow from operations for the fourth quarter decreased to $150.4 million from $155.3 million.

Risks

• The company's forward-looking statements are subject to risks and uncertainties, including judicial and administrative proceedings, governmental investigations, and changes in customer preferences and competitive conditions.
• The company acknowledges that actual events and circumstances are difficult or impossible to predict and will differ from assumptions.

Future Outlook

The company provides financial guidance for fiscal year 2025, projecting net revenue between $3.22 billion and $3.36 billion, adjusted EBITDA between $670 million and $710 million, and free cash flow between $180 million and $220 million.

Management Comments

• Suzanne Foster, Chief Executive Officer of AdaptHealth, stated that progress on the company's five areas of focus helped drive solid fourth-quarter results and is strengthening the foundation for long-term success and growth.

Industry Context

AdaptHealth operates in the healthcare-at-home solutions market, providing home medical equipment, medical supplies, and related services. The company competes with other national and regional providers of similar services and products. The increasing demand for home-based healthcare services due to factors like an aging population and technological advancements is a key industry trend.

Comparison to Industry Standards

• It is difficult to provide a detailed comparison to industry standards without specific competitor data.
• However, companies like Lincare, Apria Healthcare (now part of Owens & Minor), and Rotech Healthcare are key players in similar segments.
• Comparing AdaptHealth's growth rates, profitability margins (Adjusted EBITDA Margin of 21.1% for full year 2024), and free cash flow generation to these competitors would provide a more comprehensive assessment of its performance relative to industry benchmarks.
• For example, if Lincare has a similar EBITDA margin, AdaptHealth's results would be considered on par, but if Lincare's margin is significantly higher, it may indicate areas for AdaptHealth to improve efficiency.

Stakeholder Impact

• Shareholders will likely react positively to the improved full-year profitability and increased free cash flow.
• Employees may benefit from the company's improved financial performance and future growth prospects.
• Customers should continue to receive patient-centered, healthcare-at-home solutions.
• The company's financial stability could positively impact suppliers and creditors.

Next Steps

• Management will host a teleconference on February 25, 2025, to discuss the results and business activities with analysts and investors.
• Interested parties can access a replay of the call on the company's website for six months.

Key Dates

Keywords

AdaptHealth, financial results, healthcare-at-home, EBITDA, revenue, net income, free cash flow, guidance